Αποτελέσματα Αναζήτησης
15 Μαρ 2022 · These observations may aid obstetricians and gynecologists in weighing up the benefits and risks associated with oxytocin in prevention and treatment of PPH during the third stage of labor. Keywords: Oxytocin, side-effects, postpartum hemorrhage, meta-analysis, systematic review, randomized controlled trials.
- Figure 3
Figure 3 - Side-effects of oxytocin in postpartum...
- Table 1
Table 1 - Side-effects of oxytocin in postpartum hemorrhage:...
- Open in a Separate Window
Open in a Separate Window - Side-effects of oxytocin in...
- Figure 3
23 Ιαν 2021 · We included any randomized or nonrandomized study published in peer-reviewed journals that compared at least 2 different dosing regimens of intravenous oxytocin for postpartum hemorrhage prevention in women undergoing cesarean delivery.
4 Δεκ 2020 · Learning Objectives. Recognize the importance of risk assessment of pregnant women to identify PPH risk factors in the antenatal period and during labor and birth. Recognize the importance of coagulation tests in women with PPH, to enable early identification and treatment of coagulopathy and hyperfibrinolysis.
1 Φεβ 2023 · Use of second-line uterotonics such as methylergonovine, misoprostol, and carboprost in combination with oxytocin has an additive or synergistic effect and a greater risk reduction for postpartum hemorrhage prevention compared with oxytocin alone.
14 Απρ 2016 · Postpartum haemorrhage (PPH) is the single leading cause of maternal mortality worldwide. Most of the deaths associated with PPH occur in resource‐poor settings where effective methods of prevention and treatment ‐ such as oxytocin ‐ are not accessible because many births still occur at home, or in community settings, far from a health facility.
23 Ιουν 2024 · Given the prevailing uncertainty surrounding the impact of oxytocin on postpartum hemorrhage, the primary objective of this study is to elucidate the nuanced role of oxytocin in the context of enhanced management of this critical and potentially life-threatening obstetric complication following childbirth.
The World Health Organization guidelines state that there is insufficient evidence to recommend a speci fic oxytocin dosing regimen to prevent women from experiencing postpartum hemorrhage following a cesarean delivery.
